EUVIMEDEUVIMED entdecken
Querschnittstudie

Assessing disease activity in polymyalgia rheumatica using the systemic immune-inflammation index: A retrospective cross-sectional study

Sibel Ösken, Başak Bilir Kaya

Clinical Rheumatology · 2026-05 · 45 (5) · 2789-2797

DOI: 10.1007/s10067-026-08036-8 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Clinical Rheumatology, online erschienen am 14.03.2026. Verfasst von Sibel Ösken und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Istanbul Erenköy Physical Therapy and Rehabilitation Hospital, Merdivenköy, Ressam Salih Erimez Cad No:21, 34732, Kadıköy…. Hauptthemen laut MEDLINE: Polymyalgia Rheumatica, Inflammation. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Polymyalgia rheumatica (PMR) is an inflammatory rheumatic condition predominantly affecting older individuals, characterized by pain and stiffness in the shoulder and pelvic girdles. The PMR Activity Score (PMR-AS) is a composite tool for assessing disease activity, yet easily accessible inflammatory biomarkers that correlate with disease activity remain limited. The Systemic Immune-Inflammation Index (SII), derived from peripheral blood counts has emerged as a novel marker reflecting systemic inflammation. OBJECTIVE: To investigate the relationship between the SII index and disease activity as measured by the PMR-AS in patients diagnosed with PMR. METHODS: In this retrospective cross-sectional study, 180 patients diagnosed with PMR were included. Clinical and laboratory data at diagnosis were analyzed. PMR-AS was calculated at baseline. Pretreatment complete blood counts were used to determine the SII index. The association between SII index and PMR-AS was evaluated using Pearson correlation analysis. Patients were stratified into low disease activity and moderate-high disease activity groups based on a PMR-AS cut-off of 7. Multivariate linear regression was conducted to evaluate the independent association between SII index and PMR-AS. RESULTS: Among 180 patients with PMR, 86 (47.8%) had moderate-high disease activity. Coronary artery disease (CAD) was significantly more common in this group. Patients with moderate-high disease activity showed elevated WBC and neutrophil counts, reduced lymphocyte counts, and higher CRP levels. The SII index was markedly higher in the moderate-high disease activity group and demonstrated a moderate correlation with PMR-AS (r = 0.47). In multivariate analysis, CAD and SII index were independent predictors of moderate-high disease activity. ROC analysis confirmed that SII index demonstrated acceptable discriminatory performance moderate-high disease activity. CONCLUSION: The SII index may reflect disease activity in PMR and could be considered a non-invasive, cost-effective adjunct to clinical evaluation. Key Points • The SII index is a powerful predictor of disease activity in PMR. • Presence of CAD and higher SII index were independently associated with moderate-high disease activity, highlighting systemic inflammation. • Routine assessment of SII index may improve disease monitoring in PMR, supporting its integration into clinical evaluation alongside established disease activity scores.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyalgia RheumaticaInflammationHumansCross-Sectional StudiesFemaleRetrospective StudiesMaleAgedSeverity of Illness IndexBiomarkersMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

Biological markersDisease activityInflammationPolymyalgia rheumaticaSystemic immune-inflammation index

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Rheumatology, Istanbul Erenköy Physical Therapy and Rehabilitation Hospital, Merdivenköy, Ressam Salih Erimez Cad No:21, 34732, Kadıköy, Istanbul, Türkiye. sibeltos@yahoo.com.
  • Department of Physical Therapy and Rehabilitation, Istanbul Erenköy Physical Therapy and Rehabilitation Hospital, Istanbul, Türkiye.

Zitieren

APA

Ösken, S., & Bilir Kaya, B. (2026). Assessing disease activity in polymyalgia rheumatica using the systemic immune-inflammation index: A retrospective cross-sectional study. Clinical Rheumatology, 45(5), 2789-2797. https://doi.org/10.1007/s10067-026-08036-8

Vancouver

Ösken S, Bilir Kaya B. Assessing disease activity in polymyalgia rheumatica using the systemic immune-inflammation index: A retrospective cross-sectional study. Clinical Rheumatology. 2026;45(5):2789-2797. doi:10.1007/s10067-026-08036-8

BibTeX
@article{sken2026,
  author = {Ösken, Sibel and Bilir Kaya, Başak},
  title = {Assessing disease activity in polymyalgia rheumatica using the systemic immune-inflammation index: A retrospective cross-sectional study},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {5},
  pages = {2789--2797},
  doi = {10.1007/s10067-026-08036-8}
}
Kostenlos starten →